EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+8.73%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$1.22B
(+47%)
Cap. Flow
+$338M
Cap. Flow
% of AUM
27.68%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
96
New
33
Increased
24
Reduced
16
Closed
17
Top Buys
| 1 |
ARK Genomic Revolution ETF
ARKG
|
$71.6M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$32.8M |
| 3 |
Community Health Systems
CYH
|
$32.4M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$26.5M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$24.1M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$23.6M |
| 2 |
The Ensign Group
ENSG
|
$16.9M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$12.3M |
| 4 |
HSKA
Heska Corp
HSKA
|
$11M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$9.78M |
Sector Composition
| 1 | Healthcare | 92.79% |
| 2 | Consumer Discretionary | 0.09% |
| 3 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
26
DELISTED
Zogenix, Inc.
ZGNX
| $16.1M | 1.21% |
823,229
-86,479
| -10% | -$1.69M |
|
|
DCPH
27
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.5M | 1.17% |
345,717
+99,477
| +40% | +$4.46M |
|
|
TARO
28
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $12.1M | 0.91% |
164,378
+12,122
| +8% | +$894K |
|
29
Alnylam Pharmaceuticals
ALNY
$58.6B
| $11.4M | 0.86% |
+80,937
| New | +$11.4M |
|
30
Acadia Pharmaceuticals
ACAD
$4.34B
| $10.8M | 0.81% |
+420,000
| New | +$10.8M |
|
31
Humana
HUM
$37.5B
| $10.4M | 0.78% |
+24,839
| New | +$10.4M |
|
|
ITCI
32
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.2M | 0.77% |
300,587
-55,648
| -16% | -$1.89M |
|
33
argenx
ARGX
$44.2B
| $9.88M | 0.74% |
+35,886
| New | +$9.88M |
|
34
ARK Innovation ETF
ARKK
$7.43B
| $9.84M | 0.74% |
+82,000
| New | +$9.84M |
|
|
MGLN
35
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.76M | 0.73% |
104,700
| – | – |
|
36
Cigna
CI
$80.2B
| $9.67M | 0.73% |
+40,000
| New | +$9.67M |
|
37
MannKind Corp
MNKD
$1.69B
| $8.49M | 0.64% |
+2,165,383
| New | +$8.49M |
|
|
AFMD
38
DELISTED
Affimed
AFMD
| $8.27M | 0.62% |
1,046,129
+81,422
| +8% | +$644K |
|
39
DexCom
DXCM
$30.9B
| $6.74M | 0.51% |
18,741
+16,268
| +658% | +$5.85M |
|
40
Guardant Health
GH
$8.11B
| $6.14M | 0.46% |
+40,247
| New | +$6.14M |
|
41
Novavax
NVAX
$1.2B
| $6.07M | 0.46% |
+33,473
| New | +$6.07M |
|
42
Natera
NTRA
$23B
| $5.86M | 0.44% |
+57,700
| New | +$5.86M |
|
43
Centene
CNC
$14.8B
| $5.82M | 0.44% |
+91,120
| New | +$5.82M |
|
|
SRGA
44
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $5.75M | 0.43% |
+2,639,784
| New | +$5.75M |
|
|
KDMN
45
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.34M | 0.4% |
1,373,119
-1,035,766
| -43% | -$4.03M |
|
46
Seres Therapeutics
MCRB
$162M
| $4.43M | 0.33% |
215,276
-118,773
| -36% | -$2.45M |
|
|
LMNX
47
DELISTED
Luminex Corp
LMNX
| $4.33M | 0.33% |
+135,471
| New | +$4.33M |
|
48
Immunovant
IMVT
$2.91B
| $3.69M | 0.28% |
+230,183
| New | +$3.69M |
|
|
FPRX
49
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.51M | 0.26% |
93,280
-115,875
| -55% | -$4.37M |
|
|
50
The Ensign Group
ENSG
$9.9B
| $2.71M | 0.2% |
28,883
-179,587
| -86% | -$16.9M |
|